Author | Anna D. Garrett, PharmD, BCPS


Bariatric surgery affects postoperative warfarin dosing

November 12, 2013

A small study of patients undergoing bariatric surgery suggests that weekly warfarin doses can change by as much as 20% postoperatively.

Ticagrelor tops prasugrel in pharmacodynamic study

September 15, 2012

Ticagrelor is shown to be better at platelet inhibition. Warfarin seen as beneficial to patients with PAH. Dabigatran's problems aren't over.

Fondaparinux safe in renal impairment

August 10, 2012

Fondaparinux shown to be safe for patients with renal impairment.

Panel says no to rivaroxaban for ACS

July 15, 2012

FDA says no to rivaroxaban for ACS. ACCP updates DVT evidence. Fatal bleeds from dabigatran have tapered off